Saturday, February 9, 2019

Circulating antioxidants and Alzheimer disease prevention: A Mendelian randomization study

While this one failed, this type of research is EXACTLY what we need to know. Which circulating micronutients will prevent dementia and what ARE THE EXACTS AMOUNTS TO CONSUME to get to those levels. Guidelines are worthless, fire anyone who suggests guidelines, we can't have such lazy people stay in the stroke field.

Circulating antioxidants and Alzheimer disease prevention: A Mendelian randomization study


American Journal of Clinical NutritionWilliams DM, et al. | February 04, 2019
Advertisement
In this study, researchers determined if long-term circulating antioxidant exposure plays a role in Alzheimer disease (AD) etiology by testing the premise that AD risk would be lower in individuals with lifelong, genetically predicted increases in concentrations of four circulating antioxidants that are modifiable by diet. To that end, they performed two-sample Mendelian randomization analyses, and investigated single-nucleotide polymorphisms (SNPs) that determine variation in circulating ascorbate (vitamin C), β-carotene, retinol (vitamin A), and urate by analyzing published genetic-association studies. Using data of a genome-wide association study of late-onset AD cases and controls (n=17,008 and 37,154, respectively), they extracted statistics for genotype associations with AD risk for each set of SNP data. According to findings, no lowered risk of AD was observed in association with higher exposure to ascorbate, β-carotene, retinol, or urate. Replication Mendelian randomization studies could assess this further, providing larger AD case-control samples and, ideally, using additional variants to instrument each exposure.
Read the full article on American Journal of Clinical Nutrition

No comments:

Post a Comment